Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|December 27, 2008
Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysisG von Minckwitz, M Schwenkglenks, T Skacel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2008
Practical guidance for the management of aromatase inhibitor-associated bone lossP Hadji, J-J Body, M S Aapro, et al.European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancerL Repetto, L Biganzoli, C H Koehne, et al.British Journal of Cancer|December 6, 2000
Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potentialA D Roth, C R Berney, S Rohner, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatmentP Hadji, M S Aapro, J J Body, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?T De Pas, F De Braud, L Orlando, et al.Critical Reviews in Oncology/Hematology|February 16, 2007
Organization of the clinical activity of geriatric oncology: report of a SIOG (International Society of Geriatric Oncology) task forceSilvio Monfardini, M S Aapro, J M Bennett, et al.Cancer Treatment Reviews|March 21, 2012
Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?P Hadji, M Gnant, J J Body, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with taxol and conventional antineoplastic agentsM Vogel, S G Hilsenbeck, H Depenbrock, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Proposal for classifying the acute emetogenicity of cancer chemotherapyP J Hesketh, M G Kris, S M Grunberg, et al.Pageof 8